Argenica Therapeutics (ASX:AGN) Notes Receivable: A$0.00 Mil (As of Dec. 2025)


ASX:AGN Argenica Therapeutics Ltd ASX:AGN
33 GF Score
Price A$0.12
! 1 Warning Sign
View Full Analysis

What is Argenica Therapeutics Notes Receivable?

Argenica Therapeutics ASX:AGN +9.09% 33 Notes Receivable is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:AGN with a GF Score™ of 33/100. The stock has 1 warning sign investors should review.

Argenica Therapeutics's Notes Receivable for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Argenica Therapeutics Notes Receivable Related Terms

Argenica Therapeutics Notes Receivable Historical Data

* Premium members only.

The historical data trend for Argenica Therapeutics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Argenica Therapeutics Notes Receivable Chart

Argenica Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Argenica Therapeutics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:AGN
33GF Score
Argenica Therapeutics Ltd ASX:AGN
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Argenica Therapeutics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of A$0.00 Mil mean?
Argenica Therapeutics (ASX:AGN) has a Notes Receivable of A$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Argenica Therapeutics and its competitors.
Is Argenica Therapeutics' Notes Receivable too high?
Argenica Therapeutics' current Notes Receivable is A$0.00 Mil. Overall, Argenica Therapeutics has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Argenica Therapeutics' Notes Receivable compare to VRTX and REGN?
Argenica Therapeutics' Notes Receivable of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Argenica Therapeutics and its competitors. Argenica Therapeutics's current Notes Receivable is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Argenica Therapeutics stock overvalued right now?
Argenica Therapeutics (ASX:AGN) has a current Notes Receivable of A$0.00 Mil. The current Notes Receivable is A$0.00 Mil. Argenica Therapeutics' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Argenica Therapeutics (ASX:AGN), the current Notes Receivable is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Argenica Therapeutics Business Description

Address 117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the research and development of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and its non-clinical studies to other indications and regulatory consultants.
33GF Score

Get the complete analysis for ASX:AGN

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.12
Price